Cediranib in combination with olaparib in patients without a germline BRCA1/2 mutation with recurrent platinum-resistant ovarian cancer: Phase IIb CONCERTO trial. Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Lee, Jung-min; Moore, Richard G.; Ghamande, Sharad A.; Park, Min S.; Diaz, John Paul; Chapman, Julia A.; Kendrick, James Erasmus; Slomovitz, Brian M.; Tewari, Krishnansu Sujata; Lowe, Elizabeth S.; Milenkova, Tsveta; Kumar, Sanjeev; Dymond, Mike; Kozarewa, Iwanka; Liu, Joyce F.

authors

Publication Date

  • May 20, 2020

webpage

published in

category

volume

  • 38

issue

  • 15